{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:20:11Z","timestamp":1776673211212,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-026-01910-6","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:13:20Z","timestamp":1776669200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Malignant Transformation of Sinonasal Papilloma: Assessment of Clinicopathologic Features, p16 and p53 Expression, Transcriptionally Active HPV Status and Underlying Molecular Alterations"],"prefix":"10.1007","volume":"20","author":[{"given":"Sara E.","family":"Amin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiri","family":"Sono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubaidah I.","family":"Al-Jumaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel","family":"Ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Fan","family":"Hang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Elsayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Saluja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"1","key":"1910_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12105-021-01406-5","volume":"16","author":"LDR Thompson","year":"2022","unstructured":"Thompson LDR, Bishop JA (2022) Update from the 5th Edition of the World Health Organization classification of head and neck tumors: nasal cavity, paranasal sinuses and skull base. Head Neck Pathol 16(1):1\u201318. https:\/\/doi.org\/10.1007\/s12105-021-01406-5","journal-title":"Head Neck Pathol"},{"issue":"9","key":"1910_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/PAS.0000000000002431","volume":"49","author":"A Mehreen","year":"2025","unstructured":"Mehreen A, Mehrad M, Ely KA, Hang JF, Kuo YJ, Velez-Torres JM et al (2025) Condylomatous sinonasal papilloma-a distinct (fourth) subtype that is commonly associated with low-risk human papillomavirus. Am J Surg Pathol 49(9):873\u2013881. https:\/\/doi.org\/10.1097\/PAS.0000000000002431","journal-title":"Am J Surg Pathol"},{"key":"1910_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151504","volume":"46","author":"S Maisch","year":"2020","unstructured":"Maisch S, Mueller SK, Traxdorf M, Weyerer V, Stoehr R, Iro H et al (2020) Sinonasal papillomas: a single centre experience on 137 cases with emphasis on malignant transformation and EGFR\/KRAS status in \u201ccarcinoma ex papilloma.\u201d Ann Diagn Pathol 46:151504. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151504","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"1910_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12105-014-0527-7","volume":"8","author":"J Nudell","year":"2014","unstructured":"Nudell J, Chiosea S, Thompson LD (2014) Carcinoma ex-Schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature. Head Neck Pathol 8(3):269\u2013286. https:\/\/doi.org\/10.1007\/s12105-014-0527-7","journal-title":"Head Neck Pathol"},{"issue":"8","key":"1910_CR5","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1007\/s00405-017-4571-2","volume":"274","author":"M Re","year":"2017","unstructured":"Re M, Gioacchini FM, Bajraktari A, Tomasetti M, Kaleci S, Rubini C et al (2017) Malignant transformation of sinonasal inverted papilloma and related genetic alterations: a systematic review. Eur Arch Otorhinolaryngol 274(8):2991\u20133000. https:\/\/doi.org\/10.1007\/s00405-017-4571-2","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"1910_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12105-017-0779-0","volume":"11","author":"LM Rooper","year":"2017","unstructured":"Rooper LM, Bishop JA, Westra WH (2017) Transcriptionally active high-risk Human Papillomavirus is not a common etiologic agent in the malignant transformation of inverted Schneiderian papillomas. Head Neck Pathol 11(3):346\u2013353. https:\/\/doi.org\/10.1007\/s12105-017-0779-0","journal-title":"Head Neck Pathol"},{"issue":"3","key":"1910_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/PAS.0000000000001411","volume":"44","author":"M Mehrad","year":"2020","unstructured":"Mehrad M, Stelow EB, Bishop JA, Wang X, Haynes W, Oliver D et al (2020) Transcriptionally active HPV and targetable EGFR mutations in sinonasal inverted papilloma: An association between low-risk HPV, condylomatous morphology, and cancer risk? Am J Surg Pathol 44(3):340\u2013346. https:\/\/doi.org\/10.1097\/PAS.0000000000001411","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1910_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00428-023-03601-x","volume":"483","author":"A Kakkar","year":"2023","unstructured":"Kakkar A, Satapathy S, Sikka K, Tanwar P, Deo S, Jain D (2023) Evaluation of high-risk human papillomavirus in sinonasal papillomas and squamous cell carcinomas. Virchows Arch 483(3):381\u2013392. https:\/\/doi.org\/10.1007\/s00428-023-03601-x","journal-title":"Virchows Arch"},{"issue":"2","key":"1910_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/annonc\/mdx736","volume":"29","author":"AM Udager","year":"2018","unstructured":"Udager AM, McHugh JB, Goudsmit CM, Weigelin HC, Lim MS, Elenitoba-Johnson KSJ et al (2018) Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. Ann Oncol 29(2):466\u2013471. https:\/\/doi.org\/10.1093\/annonc\/mdx736","journal-title":"Ann Oncol"},{"issue":"4","key":"1910_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/path.4750","volume":"239","author":"AM Udager","year":"2016","unstructured":"Udager AM, McHugh JB, Betz BL, Montone KT, Livolsi VA, Seethala RR et al (2016) Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma. J Pathol 239(4):394\u2013398. https:\/\/doi.org\/10.1002\/path.4750","journal-title":"J Pathol"},{"issue":"13","key":"1910_CR11","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1158\/0008-5472.can-15-0340","volume":"75","author":"AM Udager","year":"2015","unstructured":"Udager AM, Rolland DCM, McHugh JB, Betz BL, Murga-Zamalloa C, Carey TE et al (2015) High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res 75(13):2600\u20132606. https:\/\/doi.org\/10.1158\/0008-5472.can-15-0340","journal-title":"Cancer Res"},{"issue":"6","key":"1910_CR12","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/hed.28084","volume":"47","author":"M Henrion","year":"2025","unstructured":"Henrion M, Costes-Martineau V, Bravo IG, Boulle N, Solassol J, Vendrell J et al (2025) Oncogenic human papillomaviruses drive one-third of sinonasal squamous cell carcinoma and are not mutually exclusive for gene mutations. Head Neck 47(6):1726\u20131735. https:\/\/doi.org\/10.1002\/hed.28084","journal-title":"Head Neck"},{"issue":"1","key":"1910_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64901-z","volume":"14","author":"S Kwon","year":"2024","unstructured":"Kwon S, Kim JW, Kim ES, Paik JH, Chung JH, Cho SW et al (2024) Assessment of TP53 and CDKN2A status as predictive markers of malignant transformation of sinonasal inverted papilloma. Sci Rep 14(1):14286. https:\/\/doi.org\/10.1038\/s41598-024-64901-z","journal-title":"Sci Rep"},{"issue":"6","key":"1910_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41379-020-00716-3","volume":"34","author":"NA Brown","year":"2021","unstructured":"Brown NA, Plouffe KR, Yilmaz O, Weindorf SC, Betz BL, Carey TE et al (2021) TP53 mutations and CDKN2A mutations\/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Mod Pathol 34(6):1133\u20131142. https:\/\/doi.org\/10.1038\/s41379-020-00716-3","journal-title":"Mod Pathol"},{"issue":"8","key":"1910_CR15","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/hed.26134","volume":"42","author":"E Cohen","year":"2020","unstructured":"Cohen E, Coviello C, Menaker S, Martinez-Duarte E, Gomez C, Lo K et al (2020) P16 and human papillomavirus in sinonasal squamous cell carcinoma. Head Neck 42(8):2021\u20132029. https:\/\/doi.org\/10.1002\/hed.26134","journal-title":"Head Neck"},{"issue":"12","key":"1910_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000006424","volume":"96","author":"X Wang","year":"2017","unstructured":"Wang X, Lv W, Qi F, Gao Z, Yang H, Wang W et al (2017) Clinical effects of p53 overexpression in squamous cell carcinoma of the sinonasal tract: a systematic meta-analysis with PRISMA guidelines. Medicine (Baltimore) 96(12):e6424. https:\/\/doi.org\/10.1097\/md.0000000000006424","journal-title":"Medicine (Baltimore)"},{"key":"1910_CR17","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin22.143","author":"M Menendez","year":"2022","unstructured":"Menendez M, Cabal VN, Vivanco B, Suarez-Fernandez L, Lopez F, Llorente JL et al (2022) Loss of p16 expression is a risk factor for recurrence in sinonasal inverted papilloma. Rhinology. https:\/\/doi.org\/10.4193\/Rhin22.143","journal-title":"Rhinology"},{"issue":"1","key":"1910_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-024-01690-x","volume":"18","author":"SE Amin","year":"2024","unstructured":"Amin SE, Lewis JS Jr., Bridge JA, Hang JF, Naik U, Bishop JA et al (2024) DEK::AFF2 fusion-associated squamous cell carcinoma: a case series with literature review on an emerging and challenging entity. Head Neck Pathol 18(1):86. https:\/\/doi.org\/10.1007\/s12105-024-01690-x","journal-title":"Head Neck Pathol"},{"issue":"11","key":"1910_CR19","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/s41379-022-01117-4","volume":"35","author":"YJ Kuo","year":"2022","unstructured":"Kuo YJ, Lewis JS Jr., Truong T, Yeh YC, Chernock RD, Zhai C et al (2022) Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract. Mod Pathol 35(11):1587\u20131595. https:\/\/doi.org\/10.1038\/s41379-022-01117-4","journal-title":"Mod Pathol"},{"key":"1910_CR20","unstructured":"Ion Torrent Genexus System Flyer. 2021. https:\/\/assets.thermofisher.com\/TFS-Assets\/CSD\/Flyers\/oncomine-precision-assay-flyer.pdf."},{"issue":"23","key":"1910_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000011025","volume":"97","author":"L Zhang","year":"2018","unstructured":"Zhang L, Hu C, Zheng X, Wu D, Sun H, Yu W et al (2018) Oncocytic Schneiderian papilloma-associated adenocarcinoma and KRAS mutation: a case report. Medicine (Baltimore) 97(23):e11025. https:\/\/doi.org\/10.1097\/md.0000000000011025","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"1910_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/jmcb\/mjz026","volume":"11","author":"AJ Levine","year":"2019","unstructured":"Levine AJ (2019) The many faces of p53: something for everyone. J Mol Cell Biol 11(7):524\u2013530. https:\/\/doi.org\/10.1093\/jmcb\/mjz026","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"1910_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s1535-6108(02)00102-2","volume":"2","author":"CJ Sherr","year":"2002","unstructured":"Sherr CJ, McCormick F (2002) The RB and p53 pathways in cancer. Cancer Cell 2(2):103\u2013112. https:\/\/doi.org\/10.1016\/s1535-6108(02)00102-2","journal-title":"Cancer Cell"},{"issue":"11","key":"1910_CR24","doi-asserted-by":"publisher","first-page":"12951","DOI":"10.18632\/oncotarget.7339","volume":"7","author":"S Trino","year":"2016","unstructured":"Trino S, Iacobucci I, Erriquez D, Laurenzana I, De Luca L, Ferrari A et al (2016) Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients. Oncotarget 7(11):12951\u201312961. https:\/\/doi.org\/10.18632\/oncotarget.7339","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"1910_CR25","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1007\/s12105-012-0369-0","volume":"6","author":"JS Lewis Jr.","year":"2012","unstructured":"Lewis JS Jr. (2012) p16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 6(Suppl 1):S75-82. https:\/\/doi.org\/10.1007\/s12105-012-0369-0","journal-title":"Head Neck Pathol"},{"issue":"8","key":"1910_CR26","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cncr.29901","volume":"122","author":"LJ McDowell","year":"2016","unstructured":"McDowell LJ, Young RJ, Johnston ML, Tan TJ, Kleid S, Liu CS et al (2016) p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: no association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary. Cancer 122(8):1201\u20131208. https:\/\/doi.org\/10.1002\/cncr.29901","journal-title":"Cancer"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-026-01910-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-026-01910-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-026-01910-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:13:26Z","timestamp":1776669206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-026-01910-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1007\/s12105-026-01910-6","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in the surgical pathology archives of the University of Texas Health Science Center and Memorial Hermann Hospital in accordance and compliance with the guidelines of our institutional review board authorization (HSC-MS-23-0597).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"Not available (retrospective study).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}